EPO and retinal degeneration: Intraocular delivery of EPO prevents an increase in GFAP in Müller cells in the retinal degeneration slow mouse.[16] However, in this study, consistent with our previous studies, systemic gene delivery of EPO-R76E did not decrease Müller cell reactivity.